The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Everyone loves it when youre happy and clapping along, I added again 293 yesterday, you should know by now I dont bail. Youve had a monumental run fair play, but we all know its retracing. Like it did every time previously
I have made money each time, I have gone short, if I listened to people every time they said you are making a mistake. I would never make any money. I dont expect anyone to agree with me, why would you? everyone is dreaming of £4.
At 288.5 its retrace time to the tune of https://www.youtube.com/watch?v=-3qqHdiewSE&list=PL7SijlHyQmVU7Jvr0CnB-hIWXpRQmSvJE&index=13
Ok me lovelies you have a good run, now its time for a retrace, im short. Usual rules apply, play nice, no name calling. Shorting also makes a market in at 273.23 to start. 265 will do me nicely then you can head off to £3 for Christmas
So you invested in angle without knowing their FDA application was for metastatic breast cancer, they chose one cancer type as it was years of studies, samples to get it approved for metastatic breast cancer. You wouldnt put the application in for every cancer type. As that would have simply taken forever. .